165 related articles for article (PubMed ID: 11772998)
1. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.
Harris JD; Graham IR; Schepelmann S; Stannard AK; Roberts ML; Hodges BL; Hill V; Amalfitano A; Hassall DG; Owen JS; Dickson G
Hum Mol Genet; 2002 Jan; 11(1):43-58. PubMed ID: 11772998
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice.
Athanasopoulos T; Owen JS; Hassall D; Dunckley MG; Drew J; Goodman J; Tagalakis AD; Riddell DR; Dickson G
Hum Mol Genet; 2000 Oct; 9(17):2545-51. PubMed ID: 11030760
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice.
Juan SH; Lee TS; Tseng KW; Liou JY; Shyue SK; Wu KK; Chau LY
Circulation; 2001 Sep; 104(13):1519-25. PubMed ID: 11571246
[TBL] [Abstract][Full Text] [Related]
6. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
[TBL] [Abstract][Full Text] [Related]
8. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.
Rinaldi M; Catapano AL; Parrella P; Ciafrè SA; Signori E; Seripa D; Uboldi P; Antonini R; Ricci G; Farace MG; Fazio VM
Gene Ther; 2000 Nov; 7(21):1795-801. PubMed ID: 11110410
[TBL] [Abstract][Full Text] [Related]
10. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
Tsukamoto K; Smith P; Glick JM; Rader DJ
J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
12. Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice.
Desurmont C; Caillaud JM; Emmanuel F; Benoit P; Fruchart JC; Castro G; Branellec D; Heard JM; Duverger N
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):435-42. PubMed ID: 10669641
[TBL] [Abstract][Full Text] [Related]
13. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K
Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer.
Stevenson SC; Marshall-Neff J; Teng B; Lee CB; Roy S; McClelland A
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):479-84. PubMed ID: 7749859
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7).
Evans V; Foster H; Graham IR; Foster K; Athanasopoulos T; Simons JP; Dickson G; Owen JS
Hum Gene Ther; 2008 Jun; 19(6):569-78. PubMed ID: 18578629
[TBL] [Abstract][Full Text] [Related]
20. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
